NCT01391286

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

A Multicenter, Double-masked, Randomized, Parallel-group Study Assessing the Safety and Efficacy of Once-daily Application of Bimatoprost Solution 0.03% Compared to Vehicle to Treat Chemotherapy-induced Hypotrichosis of the Eyelashes in Japanese Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Allergan · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes following chemotherapy treatment.

Conditions

• Eyelash Hypotrichosis

Interventions

Type	Name	Description
DRUG	bimatoprost solution 0.03%	One drop of bimatoprost solution 0.03% applied along each upper eyelid margin once daily in the evening for 4 months.
DRUG	bimatoprost vehicle solution	One drop of bimatoprost vehicle solution applied along each upper eyelid margin once daily in the evening for 4 months.

Timeline

• Start date: 2011-07-01
• Primary completion: 2012-05-25
• Completion: 2012-05-25
• First posted: 2011-07-12
• Last updated: 2019-07-08
• Results posted: 2013-07-09

Locations

1 site across 1 country: Japan